Private company

PROLUNG INC

PROLUNG INC is an American surgical and medical instruments and apparatus company.¹ It is headquartered in Salt Lake City, Utah.¹

Last updated Oct 20, 2026.

Overview

IndustrySurgical & Medical Instruments & Apparatus¹
HeadquartersSalt Lake City, Utah¹
Incorporated inDE²
Business address350 W. 800 N. Suite 214, Salt Lake City, Ut 84103²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2016

-15.8%Gross margin³

-28517.5%Operating margin³

-31539.3%Net margin³

-$2.0MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2016

Research and developmentSelling, general and admin

Cost of revenue0¢$10.2K
Research and development44¢$1.2M
Selling, general and admin46¢$1.3M
Interest10¢$265.9K

Out of $8.8K in revenue.³ The company lost money this year.

Financial statements

Fiscal year	2016
Revenue	$8.8K³
Cost of revenue	$10.2K³
Gross profit	-$1.4K³
Research and development	$1.2M³
Selling, general and admin	$1.3M³
Operating expenses
Operating income	-$2.5M³
Interest	$265.9K³
Net income	-$2.8M³
Earnings per share
Shares (weighted, basic)

Fiscal year	2016
Cash	$28.9K⁷
Current assets	$37.8K³
Property, plant and equipment
Intangible assets
Total assets	$578.0K³
Accounts payable
Current liabilities	$760.2K³
Long-term liabilities
Total liabilities	$3.4M³
Retained earnings
Shareholders’ equity	-$2.8M⁷
Shares outstanding	3.0M shares³

Fiscal year	2016
Cash from operations	-$2.0M³
Depreciation and amortization
Stock-based compensation
Capital spending	$0⁸
Free cash flow	-$2.0M
Cash from investing
Cash from financing

Compare PROLUNG INC with another company

What it owns

What PROLUNG INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$286.0K⁹ Dec 31, 2022	$282.1K⁹ Dec 31, 2021	+1.4%
Accumulated depreciation	$279.7K⁹ Dec 31, 2022	$260.9K⁹ Dec 31, 2021	+7.2%
Property and equipment, net	$6.3K⁹ Dec 31, 2022	$21.2K⁹ Dec 31, 2021	−70.4%
Operating-lease assets (leased space)	$123.4K⁹ Dec 31, 2022

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$296.5K⁹ Dec 31, 2022	$745.0K⁹ Dec 31, 2021	−60.2%

Intangibles and goodwill

Item	Latest	A year before	Change
Accumulated amortization	$66.9K⁹ Dec 31, 2022	$57.4K¹⁰ Dec 31, 2021	+16.7%
Finite-lived intangibles, net	$108.4K⁹ Dec 31, 2022	$117.9K⁹ Dec 31, 2021	−8.1%

Leadership

Who has led PROLUNG INC, and when. Pick a name to see everywhere that person has worked.

20202025

Chief executive officerSteven C. Eror Feb 24, 2016 to May 11, 2018¹¹
PresidentSteven C. Eror Aug 28, 2017 to Aug 28, 2017¹²
Chief operating officerMichael Anderson Garff Apr 19, 2016 to Apr 19, 2016¹³

Board members and other officers (8)

Board memberNeil Berkley May 14, 2018 to May 29, 2018¹⁴
Board memberJared Bauer Aug 16, 2018 to Aug 16, 2018¹⁵
Board memberJ. Scott Nixon Jun 14, 2017 to May 11, 2018¹⁶
Board memberSteven C. Eror Feb 24, 2016 to May 11, 2018¹¹
Board memberRobert W. Raybould Mar 29, 2016 to May 11, 2018¹⁷
Board memberJeffrey S. O'Driscoll Apr 22, 2016 to Apr 22, 2016¹⁸
Board memberTodd M. Morgan May 17, 2016 to May 11, 2018¹⁹
Board memberJohn C. Ruckdeschel Jun 9, 2016 to May 11, 2018²⁰

Former names

FRESH MEDICAL LABORATORIES, INC.Feb 10, 2012 to Apr 6, 2017²

Timeline

Oct 29, 20248-K Other events²¹
Sep 1, 20238-K Other events²²
Jun 28, 20228-K Shareholder vote²³
Mar 8, 20228-K Entered a material agreement; Regulation FD disclosure²⁴
Feb 3, 20228-K Regulation FD disclosure²⁵
Oct 7, 20218-K Executive or director change; Regulation FD disclosure²⁶
Feb 24, 2016New chief executive Steven C. Eror becomes CEO¹¹

Filings

21 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 6 major events, 8 other. The latest 20:

Oct 29, 20248-K EDGAR
Sep 1, 20238-K EDGAR
Aug 15, 2023NT 10-Q EDGAR
May 22, 202310-Q EDGAR
May 15, 2023NT 10-Q EDGAR
Apr 17, 202310-K EDGAR
Mar 30, 2023NT 10-K EDGAR
Nov 14, 202210-Q EDGAR
Aug 15, 202210-Q EDGAR
Jun 28, 20228-K EDGAR
May 23, 202210-Q EDGAR
May 17, 2022DEFA14A EDGAR
May 4, 2022NT 10-Q EDGAR
May 3, 2022DEFA14A EDGAR
May 3, 2022DEF 14A EDGAR
Apr 15, 202210-K EDGAR
Mar 24, 2022NT 10-K EDGAR
Mar 8, 20228-K EDGAR
Feb 3, 20228-K EDGAR
Nov 12, 202110-Q EDGAR

The 21 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How PROLUNG INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARPROLUNG INC¹
CIK0001541884
Employer ID (EIN)20-1922768¹
Filer statusNon-accelerated filer<br>smaller reporting company¹
Incorporated inDelaware¹
Fiscal year endsDecember 31¹
Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus¹
SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance¹
Business address350 W. 800 N. Suite 214, Salt Lake City, UT 84103¹
Phone(801) 736-0729¹
Shares outstanding4,614,989 as of May 22, 2023⁶
Public float$41.4M as of Jun 30, 2022⁹
On EDGAR sinceFeb 10, 2012¹
Filings256 in all: 8-K (52), 10-Q (34), 4 (20), DEFA14A (18), 3 (12), NT 10-Q (12), 10-K (11), UPLOAD (10)¹
All 35 form types
NT 10-K (8), S-1/A (8), CORRESP (7), DFAN14A (7), 5 (6), DEF 14A (6), D (5), 10-Q/A (4), SC 13D/A (4), 10-12G/A (3), 10-K/A (3), DEFC14A (3), PRE 14A (3), PREC14A (3), SC 13D (3), 3/A (2), PRRN14A (2), 10-12G (1), 4/A (1), 8-A12B (1), D/A (1), DEFR14A (1), FWP (1), PRER14A (1), S-1 (1), S-8 (1), SEC STAFF ACTION (1)
Latest filingsAnnual report (10-K) Apr 17, 2023
Quarterly report (10-Q) May 22, 2023
Proxy statement (DEF 14A) May 3, 2022
Latest 8-K (8-K) Oct 29, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPROLUNG INC filings on SEC EDGAR
2
SEC EDGARPROLUNG INC filings on SEC EDGAR
3
SEC EDGARPROLUNG INC 10-K for fiscal 2016
4
SEC EDGARPROLUNG INC 10-Q for fiscal 2022
5
SEC EDGARPROLUNG INC 10-Q for fiscal 2022
6
SEC EDGARPROLUNG INC 10-Q for fiscal 2023
7
SEC EDGARPROLUNG INC 10-K for fiscal 2016
8
SEC EDGARPROLUNG INC 10-K for fiscal 2016
9
SEC EDGARPROLUNG INC 10-K for fiscal 2022
10
SEC EDGARPROLUNG INC 10-K for fiscal 2021
11
SEC EDGARSteven C. Eror, Chief executive officer
12
SEC EDGARSteven C. Eror, President
13
SEC EDGARMichael Anderson Garff, Chief operating officer
14
SEC EDGARNeil Berkley, Board member
15
SEC EDGARJared Bauer, Board member
16
SEC EDGARJ. Scott Nixon, Board member
17
SEC EDGARRobert W. Raybould, Board member
18
SEC EDGARJeffrey S. O'Driscoll, Board member
19
SEC EDGARTodd M. Morgan, Board member
20
SEC EDGARJohn C. Ruckdeschel, Board member
21
SEC EDGAROther events
22
SEC EDGAROther events
23
SEC EDGARShareholder vote
24
SEC EDGAREntered a material agreement; Regulation FD disclosure
25
SEC EDGARRegulation FD disclosure
26
SEC EDGARExecutive or director change; Regulation FD disclosure